Repositório Científico do Instituto Nacional de Saúde >
Departamento de Genética Humana >
DGH - Artigos em revistas internacionais >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.18/630

Título: Preparation and validation of the first WHO international genetic reference panel for Fragile X syndrome
Autor: Hawkins, M.
Boyle, J.
Wright, K.E.
Elles, R,
Ramsden, S.C.
O'Grady, A.
Sweeney, M.
Barton, D.E.
Burgess, T.
Moore, M.
Burns, C.
Stacey, G.
Gray, E.
Metcalfe, P.
Hawkins, J.R.
Palavras-chave: Fragile X Syndrome
FMR1
Certified Reference Materials
Genetic Reference Panel
Doenças Genéticas
Issue Date: Jan-2011
Editora: Nature Publishing Group
Citação: Eur J Hum Genet. 2011 Jan;19(1):10-7. Epub 2010 Aug 25
Resumo: Fragile X syndrome is the most common inherited form of mental retardation. It is caused by expansion of a trinucleotide (CGG)n repeat sequence in the 5¢ untranslated region of the FMR1 gene, resulting in promoter hypermethylation and suppression of FMR1 transcription. Additionally, pre-mutation alleles in carrier males and females may result in Fragile X tremor ataxia syndrome and primary ovarian insufficiency, respectively. Fragile X is one of the most commonly requested molecular genetic tests worldwide. Quality assessment schemes have identified a wide disparity in allele sizing between laboratories. It is therefore important that clinical laboratories have access to characterized reference materials (RMs) to aid accurate allele sizing and diagnosis. With this in mind, a panel of genotyping RMs for Fragile X syndrome has been developed, which should be stable over many years and available to all diagnostic laboratories. Immortalized cell lines were produced by Epstein–Barr virus transformation of lymphocytes from consenting patients. Genomic DNA was extracted in bulk and RM aliquots were freeze-dried in glass ampoules. Twenty-one laboratories from seventeen countries participated in a collaborative study to assess their suitability. Participants evaluated the samples (blinded, in triplicate) in their routine methods alongside in-house and commercial controls. The panel of five genomic DNA samples was endorsed by the European Society of Human Genetics and approved as an International Standard by the Expert Committee on Biological Standardization at the World Health Organization
Arbitragem científica: yes
URI: http://hdl.handle.net/10400.18/630
ISSN: 1018-4813
Versão do Editor: http://www.nature.com/ejhg/journal/v19/n1/full/ejhg2010135a.html
Appears in Collections:DGH - Artigos em revistas internacionais

Files in This Item:

File Description SizeFormat
WHO FXS 2011.pdf784,62 kBAdobe PDFView/Open
Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  © 2010 www.insa.pt - Todos os direitos reservados | Feedback Ministério da Saúde

Estamos no RCAAP Governo Português separator Ministério da Educação e Ciência  Fundação para a Ciência e a Tecnologia

Financiado por:

POS_C UE